<DOC>
	<DOCNO>NCT00683384</DOCNO>
	<brief_summary>The purpose study collect post-marketing information safety Enbrel Filipino patient .</brief_summary>
	<brief_title>Study Evaluating Safety Enbrel ( Etanercept )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>All patient study center receive receive least one dose Enbrel accord approve product indication . Previously discontinue Enbrel therapy due significant safety concern .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Arthritis</keyword>
	<keyword>psoriatic</keyword>
</DOC>